Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-03-04

Clinical Trial Update: Effects of N-3 Polyunsaturated Fatty Acids On Chylomicron Secretion And Expression Of Genes That Regulate Intestinal Lipid Metabolism In Men With Type 2 Diabetes [NA]

View source ↗

Summary

An update on a completed clinical trial evaluating the effects of omega-3 polyunsaturated fatty acids on chylomicron secretion and the expression of genes that …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Omega-3 fatty acids (omega-3 fatty acids)

Snippet

Sponsor: Laval University | Conditions: Type 2 Diabetes | NA | Status: COMPLETED